| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | Executive Chairman
3 companies
Mazur Leonard L is an Executive Chairman at Citius Pharmaceuticals, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 6 buys and 0 sells.
Estimated insider holdings value: $7.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2022 | THAR Tharimmune, Inc. | Director | Buy | 25,000 | $4.00 | $100,000.00 | +25.3% | |
| Sep 27, 2019 | CTXR Citius Pharmaceuticals, Inc. | Executive Chairman | Buy | 2,234,700 | $0.90 | $2,000,279.97 | +27.9% | |
| Apr 3, 2019 | CTXR Citius Pharmaceuticals, Inc. | Executive Chairman | Buy | 1,165,048 | $1.55 | $1,799,999.16 | +17.0% | |
| Aug 13, 2018 | CTXR Citius Pharmaceuticals, Inc. | Executive Chairman | Buy | 3,137,255 | $1.28 | $4,000,000.12 | +84.4% | |
| Mar 29, 2018 | CTXR Citius Pharmaceuticals, Inc. | Executive Chairman | Buy | 167,504 | $2.99 | $499,999.44 | +4.7% | |
| Dec 19, 2017 | CTXR Citius Pharmaceuticals, Inc. | Executive Chairman | Buy | 213,106 | $4.69 | $999,467.14 | +6.4% |